Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-19 3:00 pm Purchase |
2025-03-17 | 13D | SINOVAC BIOTECH LTD SVA |
Vivo Capital IX, LLC | 4,539,456 6.300% |
4,539,456 (New Position) |
Filing History |
| 2024-11-14 6:59 pm Purchase |
2024-09-30 | 13G | Instil Bio, Inc. TIL |
Vivo Capital IX, LLC | 585,485 9.000% |
585,485 (New Position) |
Filing History |
| 2024-04-02 5:44 pm Unchanged |
2024-03-28 | 13D | Genetron Holdings Limited GTH |
Vivo Capital IX, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-13 5:03 pm Sale |
2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Vivo Capital IX, LLC | 894,826 2.700% |
-1,367,374 (-60.44%) |
Filing History |
| 2024-02-13 5:00 pm Sale |
2023-12-31 | 13G | Sera Prognostics, Inc. SERA |
Vivo Capital IX, LLC | 1,650,440 5.400% |
-205,571 (-11.08%) |
Filing History |
| 2023-10-19 4:30 pm Purchase |
2023-10-11 | 13D | Genetron Holdings Limited GTH |
Vivo Capital IX, LLC | 9,524,767 6.000% |
9,524,767 (New Position) |
Filing History |
| 2023-02-13 5:54 pm Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
Vivo Capital IX, LLC | 0 0.000% |
-5,202,348 (Position Closed) |
Filing History |
| 2023-02-13 5:52 pm Sale |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Vivo Capital IX, LLC | 2,262,200 8.500% |
-725,131 (-24.27%) |
Filing History |
| 2023-02-13 5:51 pm Unchanged |
2022-12-31 | 13G | Genetron Holdings Limited GTH |
Vivo Capital IX, LLC | 9,524,767 6.300% |
0 (Unchanged) |
Filing History |
| 2023-02-13 5:48 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Vivo Capital IX, LLC | 3,761,947 3.100% |
-5,647,104 (-60.02%) |
Filing History |
| 2023-02-13 5:44 pm Purchase |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Vivo Capital IX, LLC | 772,068 2.300% |
772,068 (New Position) |
Filing History |
| 2022-07-05 5:06 pm Sale |
2022-07-01 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 0 0.000% |
-2,735,852 (Position Closed) |
Filing History |
| 2022-02-11 5:27 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Vivo Capital IX, LLC | 326,888 1.800% |
-326,891 (-50.00%) |
Filing History |
| 2022-02-11 5:26 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Vivo Capital IX, LLC | 9,409,051 7.800% |
448,755 (+5.01%) |
Filing History |
| 2022-02-11 5:25 pm Purchase |
2021-12-31 | 13G | IVERIC bio, Inc. ISEE |
Vivo Capital IX, LLC | 5,202,348 4.500% |
324,300 (+6.65%) |
Filing History |
| 2022-02-11 5:23 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
Vivo Capital IX, LLC | 624,902 1.400% |
624,902 (New Position) |
Filing History |
| 2022-02-11 5:22 pm Purchase |
2022-01-31 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 2,735,852 14.700% |
799,999 (+41.33%) |
Filing History |
| 2022-02-11 5:21 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Vivo Capital IX, LLC | 2,987,331 14.400% |
-257,704 (-7.94%) |
Filing History |
| 2021-11-12 4:30 pm Purchase |
2021-11-09 | 13G | IO Biotech, Inc. IOBT |
Vivo Capital IX, LLC | 3,015,545 10.500% |
3,015,545 (New Position) |
Filing History |
| 2021-11-05 5:00 pm Purchase |
2021-11-05 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 1,935,853 14.800% |
480,277 (+33.00%) |
Filing History |